Fuse Science Inc (DROP)

[BeDub]

That's the commercialization phase statement that didn't happen. Excellent example of their deception. Here's some more, right from their press releases shown in the news above.

The components of the campaign include intelligent "In-Stream TV Ads" via YouTube, which began airing March 10th, 2014, and will continue over the next several months.

Fuse will begin broadcasting the "Respect the Power" campaign on select national and regional networks over the next 30 days in support of current in-store advertising currently active in Walgreens stores across the country and on Walgreens.com. This campaign represents the next phase in progressive advertising by the Company that will include Powered By Fuse® world-class athletes doing the extraordinary.

The ads will run on cable and standard television reaching a combined 80 million households across multiple networks with the objective of introducing Fuse products and educating consumers on what it means to be "Powered By Fuse!®"

Fuse Science has expanded strategic talks to the leading producers of Estrodial in the hormone replacement category as part of the company's structure active M&A and licensing process.

"We have been anxiously awaiting the results of the AREDS2 study, so that we could incorporate the findings into the new Macular Health Drop Formulation. The ideal Drop formulation is well underway and we expect to begin clinical testing in July," said Macular Health's Chief Executive officer, Jeffery McAnnally. "We believe this study paves the way for an even bigger relationship between Macular Health and Fuse Science."

Fuse Science will continue its work with the New York-based investment banking firm Atlas Strategic Advisors (www.atlasadvisors.com) to explore strategic transactions involving Fuse's proprietary technology. Additionally, Fuse Science will be advised by Gaurav Kapoor, former Managing Partner and Principal at New England Consulting Group, where he worked for 15 years, leading landmark M&A and licensing transactions in the pharmaceutical and consumer package goods industries.